Visby Medical

Visby MedicalVisby Medical
Visby Medical

Visby Medical

Visby Medical develops and manufactures instrument-free, PCR-quality rapid diagnostic tests for infectious diseases at the point of care.

2012Active179
Rate

About

Visby Medical is a diagnostics company focused on transforming the detection and treatment of infectious diseases. They develop and manufacture a portable, instrument-free, single-use PCR device that delivers accurate, lab-quality results in under 30 minutes directly at the point of care, enabling rapid diagnosis and treatment decisions.

Technology stack

detected 2026-07-03
CDN
Cloudflare
EmailGoogle Workspace
Stack
jQueryBootstrapShopify
Analytics
Google Tag Manager
Comments
(6)
6 positive0 mixed0 negative
Reddit
r/EverythingScienceu/Primary_Phase_2719Apr 3, 2025Positive

The Visby Medical Women’s Sexual Health Test is a prescription-free test that has received approval from the FDA for an innovative at-home diagnostic solution. This test detects chlamydia, gonorrhea, and trichomoniasis and delivers results…

View on Reddit
Reddit
r/FreePressu/GeneralCarlosQ17Mar 29, 2025Positive

The U.S. Food and Drug Administration on Friday granted authorization to market the first test that can be performed entirely at home for detecting three sexually transmitted infections (STIs). The home test, developed by privately held com…

View on Reddit
Reddit
r/AnythingGoesNewsu/GeneralCarlosQ17Mar 29, 2025Positive

The U.S. Food and Drug Administration on Friday granted authorization to market the first test that can be performed entirely at home for detecting three sexually transmitted infections (STIs). The home test, developed by privately held com…

View on Reddit
Reddit
r/ConservativesOnlyu/GeneralCarlosQ17Mar 29, 2025Positive

The U.S. Food and Drug Administration on Friday granted authorization to market the first test that can be performed entirely at home for detecting three sexually transmitted infections (STIs). The home test, developed by privately held com…

View on Reddit
Reddit
r/Patriot911u/GeneralCarlosQ17Mar 29, 2025Positive

The U.S. Food and Drug Administration on Friday granted authorization to market the first test that can be performed entirely at home for detecting three sexually transmitted infections (STIs). The home test, developed by privately held com…

View on Reddit
Reddit
r/ContagionCuriosityu/Anti-OwlMar 28, 2025Positive💎

The Visby Medical Women's Sexual Health Test is a single-use test intended for women with or without symptoms. The FDA granted marketing authorization to Visby Medical based on testing that showed the device correctly identified 98.8% of ne…

View on Reddit

Some comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.

Frequently asked

What does Visby Medical do?

Visby Medical is a diagnostics company focused on transforming the detection and treatment of infectious diseases. They develop and manufacture a portable, instrument-free, single-use PCR device that delivers accurate, lab-quality results in under 30 minutes directly at the point of care, enabling rapid diagnosis and treatment decisions. (formerly Click Diagnostics.)

How much funding has Visby Medical raised?

Visby Medical has raised a total of $331M in funding. The most recent round on record is Series E.

Where is Visby Medical headquartered?

Visby Medical is headquartered in San Jose, United States.

When was Visby Medical founded?

Visby Medical was founded in 2012.

What industry does Visby Medical operate in?

Visby Medical operates in Healthcare, MedTech, HealthTech, Diagnostics, Infectious Disease Diagnostics, Point-of-Care Testing.

How many employees does Visby Medical have?

Visby Medical has approximately 179 people on record.

What is Visby Medical's revenue?

StartupHub estimates Visby Medical's annual revenue at $57.7M (range $31.2M to $92.0M, 63% confidence), based on comparable companies in the sector.

What is Visby Medical's valuation?

StartupHub estimates Visby Medical's effective valuation at $616.6M (range $431.6M to $801.6M, 26% confidence), based on comparable companies in the sector.